Although we have demonstrated that effects of NADPH oxidase activation in neuronal death after hypoglycemia [26], traumatic brain injury [22], and epilepsy [21], the efficacy of inhibition of NADPH oxidase activation by apocynin treatment in seizure-induced neurogenesis has not been demonstrated. The gene discussed is FMO5; the disease is epilepsy.